Skip to main content

Advertisement

SpringerLink
Log in

Are healthcare economics a factor behind European MRSA rates?

  • Brief Report
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

Abstract

This study assessed the relationship between meticillin-resistant Staphylococcus aureus (MRSA) prevalence in 26 European countries with two key socioeconomic parameters, namely, gross domestic product per capita (GDP) and infant mortality rate (IMR). Whilst no significant relationship was identified between MRSA and GDP (Spearman correlation: −0.387; 95% confidence interval [CI]: −0.674 to 0.000; p = 0.0528), a significant correlation was evident between MRSA and IMR (Spearman correlation: 0.545; 95% CI: 0.208 to 0.766; p = 0.005). The elimination of a widely outlying data point retained significance. Various studies have shown IMR to be a good marker of healthcare expenditure and it is, therefore, reasonable to postulate that one possible factor in the multi-factorial epidemiology of MRSA in Europe is the level and effectiveness of healthcare expenditure within the individual countries.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Tiemersma EW, Bronzwaer SL, Lyytikäinen O, Degener JE, Schrijnemakers P, Bruinsma N, Monen J, Witte W, Grundman H; European Antimicrobial Resistance Surveillance System Participants (2004) Methicillin-resistant Staphylococcus aureus in Europe, 1999–2002. Emerg Infect Dis 10:1627–1634

    PubMed  Google Scholar 

  2. Babazono A, Hillman AL (1994) A comparison of international health outcomes and health care spending. Int J Technol Assess Health Care 10:376–381

    Article  CAS  PubMed  Google Scholar 

  3. Crémieux PY, Ouellette P, Pilon C (1999) Health care spending as determinants of health outcomes. Health Econ 8:627–639

    Article  PubMed  Google Scholar 

  4. de Kraker MEA, van de Sande N, Monen J, Borg MA, Kahlmeter G, Kolman J, Grundmann H; EARSS participants (2006) MRSA incidences and proportions: how well do these correlate on a European level? Paper presented at 16th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Nice, France, April 2006

  5. Elola J, Daponte A, Navarro V (1995) Health indicators and the organization of health care systems in Western Europe. Am J Public Health 85:1397–1401

    Article  CAS  PubMed  Google Scholar 

  6. Grubaugh SG, Rexford ES (1994) Comparing the performance of health care systems: an alternative approach. South Econ J 60:1030–1042

    Article  Google Scholar 

  7. Wolfe BL, Gabay M (1987) Health status and medical expenditures: more evidence of a link. Soc Sci Med 25:883–888

    Article  CAS  PubMed  Google Scholar 

  8. McCormick MC (1985) The contribution of low birth weight to infant mortality and childhood morbidity. N Engl J Med 312:82–90

    Article  CAS  PubMed  Google Scholar 

  9. Gould IM (2005) Control of methicillin-resistant Staphylococcus aureus in the UK. Eur J Clin Microbiol Infect Dis 24:789–793

    Article  CAS  PubMed  Google Scholar 

  10. Liu K, Moon M, Sulvetta M, Chawla J (1992) International infant mortality rankings: a look behind the numbers. Health Care Financ Rev 13:105–118

    CAS  PubMed  Google Scholar 

Download references

Conflicts of interest

The author does not have any conflicts of interest to declare.

Author information

Authors and Affiliations

  1. Infection Control Unit, Mater Dei Hospital, Msida, Malta

    M. A. Borg

Authors
  1. M. A. Borg
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. A. Borg.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Borg, M.A. Are healthcare economics a factor behind European MRSA rates?. Eur J Clin Microbiol Infect Dis 29, 477–479 (2010). https://doi.org/10.1007/s10096-009-0871-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-009-0871-9

Keywords

Search

Navigation